Arrow Mark Colorado Holdings LLC Neurocrine Biosciences Inc Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $49.3 Million - $56.6 Million	-571,579 Reduced 95.65%	26,020 $2.5 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $2.8 Million - $3.2 Million	-31,278 Reduced 4.97%	597,599 $58.2 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $2.59 Million - $3.53 Million	29,573 Added 4.93%	628,877 $61.2 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $4.49 Million - $5.6 Million	51,716 Added 9.44%	599,304 $57.4 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $687,736 - $966,592	-7,152 Reduced 1.29%	547,588 $52.7 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $3.51 Million - $5.38 Million	41,269 Added 8.04%	554,740 $67.7 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $1.88 Million - $2.85 Million	25,019 Added 5.12%	513,471 $44.4 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $3.95 Million - $5.4 Million	45,502 Added 10.27%	488,452 $52.5 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $4.54 Million - $5.5 Million	54,140 Added 13.92%	442,950 $39.9 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $597,208 - $754,529	-8,267 Reduced 2.08%	388,810 $32.8 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $1.27 Million - $1.68 Million	18,382 Added 4.85%	397,077 $35 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $222,928 - $405,786	3,263 Added 0.87%	378,695 $27 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $33.7 Million - $42.9 Million	-341,012 Reduced 47.6%	375,432 $46.2 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $1.94 Million - $2.72 Million	-25,703 Reduced 3.46%	716,444 $70.4 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $4.22 Million - $5.14 Million	-55,567 Reduced 6.97%	742,147 $61.5 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $5.28 Million - $7 Million	-90,232 Reduced 10.16%	797,714 $61.9 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $42.6 Million - $54.4 Million	887,946	887,946 $54.4 Million

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.52 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$782 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$391 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$283 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account